Simulations Plus Inc. expected to Report Fiscal Year 2009 Results on November 20, 2009. This event was calculated by Capital IQ (Created on November 16, 2009).

Simulations Plus Inc. announced the release of ClassPharmer 4.7, the latest version of its state-of-the-art software used by pharmaceutical research scientists for analysis of chemical libraries and design of new molecular structures. This new version of ClassPharmer further extends its data mining and molecule design capabilities with a series of powerful new enhancements, including features requested by its users as well as those developed in-house. One particularly new feature is the ability to design molecules that replace a problematic portion of an existing candidate molecule with another structure ('scaffold') expected to have improved properties. This technique, commonly called 'scaffold hopping,' is extremely important in the drug industry because it allows chemists to salvage an otherwise promising drug candidate that could not have been taken forward due to ADMET liabilities, synthetic challenges, or intellectual property restrictions. ClassPharmer's new design feature helps chemists to perform this scaffold-hopping task in silico (that is in the computer), allowing them to screen hundreds of thousands of replacement scaffolds computationally without the need to commit valuable resources to synthesize and test them all.

To overview of the business through the end of third fiscal quarter on May 31, 2009